Publicaciones en las que colabora con Manuel Soto Álvarez (23)

2022

  1. Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases

    Trends in Parasitology, Vol. 38, Núm. 4, pp. 316-334

2021

  1. Inoculation of the leishmania infantum hsp70-ii null mutant induces long-term protection against l. Amazonensis infection in balb/c mice

    Microorganisms, Vol. 9, Núm. 2, pp. 1-15

2020

  1. Resistance to Experimental Visceral Leishmaniasis in Mice Infected With Leishmania infantum Requires Batf3

    Frontiers in Immunology, Vol. 11

  2. Subcutaneous immunization of leishmania HSP70-II null mutant line reduces the severity of the experimental visceral leishmaniasis in BALB/c mice

    Vaccines, Vol. 8, Núm. 1

2018

  1. Analysis of the antigenic and prophylactic properties of the Leishmania translation initiation factors eIF2 and eIF2B in natural and experimental leishmaniasis

    Frontiers in Cellular and Infection Microbiology, Vol. 8, Núm. APR

  2. Leishmania Hijacks myeloid cells for immune escape

    Frontiers in Microbiology, Vol. 9, Núm. MAY

  3. Vaccine candidates against leishmania under current research

    Expert Review of Vaccines, Vol. 17, Núm. 4, pp. 323-334

2017

  1. Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models

    PLoS Neglected Tropical Diseases, Vol. 11, Núm. 5

2016

  1. Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to Infection

    Immunity, Vol. 45, Núm. 4, pp. 788-801

2015

  1. Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice

    PLoS Neglected Tropical Diseases, Vol. 9, Núm. 5

2011

  1. H-ras and N-ras are dispensable for T-cell development and activation but critical for protective Th1 immunity

    Blood, Vol. 117, Núm. 19, pp. 5102-5111

2010

  1. BALB/cmice vaccinated with leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge

    Journal of Biomedicine and Biotechnology, Vol. 2010

2009

  1. Key role of the 3′ untranslated region in the cell cycle regulated expression of the Leishmania infantum histone H2A genes: Minor synergistic effect of the 5′ untranslated region

    BMC Molecular Biology, Vol. 10

  2. Searching genes encoding leishmania antigens for diagnosis and protection

    Scholarly Research Exchange

2008

  1. Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice

    Microbes and Infection, Vol. 10, Núm. 10-11, pp. 1133-1141

2007

  1. The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers

    Clinical and Experimental Immunology, Vol. 150, Núm. 2, pp. 375-385

2006

  1. Immunohistological features of visceral leishmaniasis in BALB/c mice

    Parasite Immunology, Vol. 28, Núm. 5, pp. 173-183

2005

  1. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice

    Infection and Immunity, Vol. 73, Núm. 9, pp. 5842-5852

2004

  1. Cell-cycle-dependent translation of histone mRNAs is the key control point for regulation of histone biosynthesis in Leishmania infantum

    Biochemical Journal, Vol. 379, Núm. 3, pp. 617-625

  2. Recent advances in vaccines for leishmaniasis

    Expert Opinion on Biological Therapy, Vol. 4, Núm. 9, pp. 1505-1517